Clinical trial
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or…
NCT00279045 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00279045 |
|---|---|
| Title | Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide |
| Official title | A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Rosiglitazone, glyburide, metformin |
| Enrollment | 4,426 |
| Start date | Jan 3, 2000 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 19, 2006 |
| First posted | Jan 19, 2006 |
| Last update posted | Nov 29, 2017 |
| Countries | Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Netherlands and 5 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: